EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

S100A8/A9‐High Macrophages Activate Intestinal Fibroblasts via mCCL6/hCCL15‐CCR1 Axis to Drive Intestinal Fibrosis in Crohn's Disease

Shu Wang, Jiayun Wang, Junjie Lin, Ziping Ye, Geyujia Zhou, Jingjing Ma, Junjian Sun, Jiang Yu, Yingdi Zhang, Nana Tang, Chunhua Jiao iD, Xiaojing Zhao and 1 more

Advanced Science · 2026

DOI: 10.1002/advs.76353 ↗

At a glance

Journal article in Advanced Science, 2026. Written by Shu Wang and 12 co-authors. Institution: Department of Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. Major MEDLINE topics: Crohn Disease, Macrophages, Calgranulin B, Calgranulin A. 62 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Intestinal fibrosis presents a major clinical challenge in Crohn's disease (CD) due to the lack of effective pharmacological interventions. The underlying mechanisms of intestinal fibrosis remain largely elusive. Reanalysis of the single‐cell RNA‐seq data from full‐thickness CD tissue identifies a distinct profibrotic macrophage subset characterized by high S100A8 and S100A9 expression. CellChat analysis indicates strong communication between this S100A8/A9‐high (S100A8/A9 hi ) macrophage subset and fibroblasts. Adoptive transfer of S100A8/A9 hi macrophages exacerbate intestinal fibrosis in mice with chronic dextran sulfate sodium (DSS)‐induced colitis. Consequently, pharmacological inhibition of S100A8/A9 significantly ameliorates intestinal fibrosis in murine chronic colitis. Proteomic analysis further identifies murine CCL6 (mCCL6) as the key pro‐fibrotic mediator secreted by S100A8/A9 hi macrophages, which acts via CC chemokine receptor 1 (CCR1) to regulate fibroblasts. Antibody blockade of mCCL6 alleviates established intestinal fibrosis in a DSS‐induced colitis model. Mechanistically, S100A8/A9 hi macrophages drive mCCL6 production via STAT3 activation. Similarly, the human ortholog of CCL6, CCL15 (hCCL15), exerts pro‐fibrotic effects on fibroblasts via the CCR1 receptor. Our findings reveal that targeting S100A8/A9 hi macrophage may be a therapeutic strategy against intestinal fibrosis in CD.

Subjects

MeSH terms (MEDLINE)

Crohn DiseaseMacrophagesCalgranulin BCalgranulin AFibroblastsReceptors, CCR1Chemokines, CCMacrophage Inflammatory ProteinsAnimalsMiceFibrosisDisease Models, AnimalHumansMice, Inbred C57BLColitisIntestinesMale

Author keywords

Crohn's diseaseS100A8/A9‐high macrophagesintestinal fibrosismCCL6/ hCCL15

Substances

Calgranulin BCalgranulin AReceptors, CCR1Chemokines, CCCcr1 protein, mouseCcl6 protein, mouseMacrophage Inflammatory ProteinsS100A9 protein, mouseS100a8 protein, mouse

Authors and institutions

  • Department of Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.

ORCID profiles: Chunhua Jiao, Hongjie Zhang

Funding

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Cite

APA

Wang, S., Wang, J., Lin, J., Ye, Z., Zhou, G., Ma, J., Sun, J., Yu, J., Zhang, Y., Tang, N., Jiao, C., Zhao, X., & Zhang, H. (2026). S100A8/A9‐High Macrophages Activate Intestinal Fibroblasts via mCCL6/hCCL15‐CCR1 Axis to Drive Intestinal Fibrosis in Crohn's Disease. Advanced Science. https://doi.org/10.1002/advs.76353

Vancouver

Wang S, Wang J, Lin J, Ye Z, Zhou G, Ma J, et al. S100A8/A9‐High Macrophages Activate Intestinal Fibroblasts via mCCL6/hCCL15‐CCR1 Axis to Drive Intestinal Fibrosis in Crohn's Disease. Advanced Science. 2026. doi:10.1002/advs.76353

BibTeX
@article{Wang2026,
  author = {Wang, Shu and Wang, Jiayun and Lin, Junjie and Ye, Ziping and Zhou, Geyujia and Ma, Jingjing and Sun, Junjian and Yu, Jiang and Zhang, Yingdi and Tang, Nana and Jiao, Chunhua and Zhao, Xiaojing and Zhang, Hongjie},
  title = {S100A8/A9‐High Macrophages Activate Intestinal Fibroblasts via mCCL6/hCCL15‐CCR1 Axis to Drive Intestinal Fibrosis in Crohn's Disease},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76353}
}
Start for free →